Home Pain & sedation No benefit from prophylaxis for opioid nausea
Pain & sedation
No benefit from prophylaxis for opioid nausea
Prophylaxis of opioid-induced nausea in helicopter emergency medical service: a prospective quasi-experimental study
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine · Added 7 May 2026
Prospective study of 205 HEMS patients comparing ondansetron prophylaxis, aromatherapy, and no prophylaxis for opioid-induced nausea — neither intervention showed benefit compared to no prophylaxis in unselected patients.
- Study type
- Cohort
- Design
- Prospective quasi-experimental rotating-schedule study across six HEMS bases
- Participants
- 205 patients >16 given opioids for traumatic pain (86 no prophylaxis, 64 ondansetron, 55 aromatherapy)
- Main finding
- Median NRS change 0 in all groups; NRS increase in 15%, 14%, 15%; NRS>3 in 14% vs 11% vs 11%; vomiting 4%, 2%, 0%. Neither ondansetron nor aromatherapy showed benefit over no prophylaxis.
- Caveat
- Quasi-experimental rotating allocation, single HEMS system, modest sample size
- Bottom line
- Hypothesis-generating
Learning goal
Weigh whether routine antiemetic prophylaxis is warranted when giving opioids for traumatic pain in the prehospital setting.
More
- Topic: Pain & sedation
- Daily scan: 7 May 2026
Related papers on Pain & sedation
-
Procedural sedation consensus: oversight & quality
Multidisciplinary Delphi consensus guidelines covering principles, oversight, and quality monitoring for unscheduled procedural sedation.
-
Intranasal equals subcutaneous ketamine for pain
RCT testing whether intranasal ketamine is non-inferior to subcutaneous for acute traumatic pain — both routes provided equivalent analgesia with minimal clinically important differences, though minor adverse events were more common with subcutaneous administration.
-
Early non-IV analgesia in prehospital trauma
Study on: Early non-intravenous analgesia in prehospital trauma care: time to act. No abstract available for detailed assessment.
-
Droperidol for nausea: low adverse event rate
This study evaluated adverse events associated with prehospital droperidol use for nausea or vomiting — the incidence of clinically significant adverse events was low, suggesting droperidol may be safe for prehospital use.